{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:18:03Z","timestamp":1774952283176,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Disease-a-Month"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.disamonth.2021.101167","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T09:03:39Z","timestamp":1614157419000},"page":"101167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Reviewing the oral pigmented lesions of human immunodeficiency virus with emphasis on the effect of highly active antiretroviral therapy"],"prefix":"10.1016","volume":"67","author":[{"given":"Saranya","family":"Varadarajan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thodur Madapusi","family":"Balaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nalin","family":"Kumar S","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SK","family":"Indu Bharkavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopalakrishnan","family":"Thangavel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Thirumal","family":"Raj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shankargouda","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghassan M","family":"Al-Iryani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fareedi Mukram","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran Habib","family":"Awan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.disamonth.2021.101167_bib0001","series-title":"Ten Cate's Oral Histology","year":"2017"},{"issue":"11","key":"10.1016\/j.disamonth.2021.101167_bib0002","article-title":"Pigmentary disorders of oral mucosa","volume":"2","author":"Patil","year":"2015","journal-title":"J Pigment Disord"},{"issue":"78","key":"10.1016\/j.disamonth.2021.101167_bib0003","first-page":"43","article-title":"Oral manifestations of human immunodeficiency virus-infected patients","volume":"27","author":"Pakfetrat","year":"2015","journal-title":"Iran J Otorhinolaryngol"},{"key":"10.1016\/j.disamonth.2021.101167_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/8389214","article-title":"HIV-associated oral mucosal melanin hyperpigmentation: a clinical study in a South African population sample","volume":"2016","author":"Chandran","year":"2016","journal-title":"AIDS Res Treat"},{"issue":"S1","key":"10.1016\/j.disamonth.2021.101167_bib0005","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1002\/eji.200737441","article-title":"A history of AIDS: looking back to see ahead","volume":"37","author":"Greene","year":"2007","journal-title":"Eur J Immunol"},{"issue":"25","key":"10.1016\/j.disamonth.2021.101167_bib0006","first-page":"305","article-title":"Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men\u2013New York City and California","volume":"30","year":"1981","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.disamonth.2021.101167_bib0007","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/cid\/ciq248","article-title":"Update on human immunodeficiency virus (HIV)-2 infection","volume":"52","author":"Campbell-Yesufu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.disamonth.2021.101167_bib0008","unstructured":"GHO | By Category | Number of New HIV Infections - Estimates by WHO Region. Accessed 2020. https:\/\/apps.who.int\/gho\/data\/node.main.HIVINCIDENCE?lang=en"},{"issue":"4","key":"10.1016\/j.disamonth.2021.101167_bib0009","first-page":"29","article-title":"Oral manifestations of HIV infection","volume":"9","author":"Greenspan","year":"1997","journal-title":"AIDS Clin Care"},{"issue":"1","key":"10.1016\/j.disamonth.2021.101167_bib0010","first-page":"E33","article-title":"Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population","volume":"11","author":"Bravo","year":"2006","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"3","key":"10.1016\/j.disamonth.2021.101167_bib0011","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1601-0825.1996.tb00223.x","article-title":"Aetiological factors for oral manifestations of HIV","volume":"2","author":"Palmer","year":"2008","journal-title":"Oral Dis"},{"issue":"9","key":"10.1016\/j.disamonth.2021.101167_bib0012","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1600-0625.2009.00912.x","article-title":"What are melanocytes really doing all day long\u2026?","volume":"18","author":"Plonka","year":"2009","journal-title":"Exp Dermatol"},{"issue":"2","key":"10.1016\/j.disamonth.2021.101167_bib0013","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1006\/jtbi.2001.2331","article-title":"The antimicrobial properties of melanocytes, melanosomes and melanin and the evolution of black skin","volume":"211","author":"Mackintosh","year":"2001","journal-title":"J Theor Biol"},{"issue":"2","key":"10.1016\/j.disamonth.2021.101167_bib0014","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0030-4220(91)90460-T","article-title":"Oral manifestations of HIV infection and their management. II. Less common lesions","volume":"71","author":"Scully","year":"1991","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"3","key":"10.1016\/j.disamonth.2021.101167_bib0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0030-4220(89)90360-5","article-title":"Oral hyperpigmentation in HIV-infected patients","volume":"67","author":"Langford","year":"1989","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"1","key":"10.1016\/j.disamonth.2021.101167_bib0016","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/154407370601900123","article-title":"(A3) HIV phenotypes, oral lesions, and management of HIV-related disease","volume":"19","author":"Blignaut","year":"2006","journal-title":"Adv Dent Res"},{"issue":"3","key":"10.1016\/j.disamonth.2021.101167_bib0017","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-0714.2006.00505.x","article-title":"Oral lesions among persons with HIV disease with and without highly active antiretroviral therapy in southern India","volume":"36","author":"Umadevi","year":"2007","journal-title":"J Oral Pathol Med"},{"issue":"4","key":"10.1016\/j.disamonth.2021.101167_bib0018","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1079-2104(05)80367-1","article-title":"Melanocytic activation in HIV disease: HMB-45 positivity in oral melanotic macules","volume":"80","author":"Ficarra","year":"1995","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol"},{"issue":"10","key":"10.1016\/j.disamonth.2021.101167_bib0019","first-page":"556","article-title":"Insights into immunopathogenic mechanisms of HIV infection: high levels of immune activation and HIV fitness","volume":"63","author":"Feller","year":"2008","journal-title":"SADJ"},{"issue":"4","key":"10.1016\/j.disamonth.2021.101167_bib0020","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0190-9622(08)81046-8","article-title":"Pigmented nail bands and mucocutaneous pigmentation in HIV-positive patients treated with Zidovudine","volume":"22","author":"Grau-Massanes","year":"1990","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.disamonth.2021.101167_bib0021","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1067\/mjd.2002.119105","article-title":"Cutaneous manifestations of antiretroviral therapy","volume":"46","author":"Ward","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.disamonth.2021.101167_bib0022","doi-asserted-by":"crossref","first-page":"e12351","DOI":"10.1111\/jicd.12351","article-title":"Systematic review of the changing pattern of the oral manifestations of HIV","volume":"9","author":"El Howati","year":"2018","journal-title":"J Investig Clin Dent"},{"key":"10.1016\/j.disamonth.2021.101167_bib0023","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.4317\/jced.52127","article-title":"Oral manifestations of HIV\/AIDS in Asia: systematic review and future research guidelines","author":"Sharma","year":"2015","journal-title":"J Clin Exp Dent"},{"issue":"4","key":"10.1016\/j.disamonth.2021.101167_bib0024","first-page":"129","article-title":"HIV-associated oral Kaposi sarcoma and HHV-8: a review","volume":"9","author":"Feller","year":"2007","journal-title":"J Int Acad Periodontol"},{"issue":"6","key":"10.1016\/j.disamonth.2021.101167_bib0025","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S1079-2104(03)00370-6","article-title":"Oral Kaposi's sarcoma: a clinicopathologic study from South Africa","volume":"96","author":"Lager","year":"2003","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol"},{"issue":"6693","key":"10.1016\/j.disamonth.2021.101167_bib0026","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/29093","article-title":"Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus","volume":"394","author":"Flore","year":"1998","journal-title":"Nature"},{"issue":"9248","key":"10.1016\/j.disamonth.2021.101167_bib0027","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/S0140-6736(00)03503-0","article-title":"Outlook in oral and cutaneous Kaposi's sarcoma","volume":"356","author":"Rohrmus","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.disamonth.2021.101167_bib0028","first-page":"1","article-title":"Oral HIV-associated Kaposi sarcoma: a clinical study from the Ga-Rankuwa area, South Africa","volume":"2012","author":"Khammissa","year":"2012","journal-title":"AIDS Res Treat"},{"issue":"4","key":"10.1016\/j.disamonth.2021.101167_bib0029","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1601-0825.2004.01013.x","article-title":"Ranula: another HIV\/AIDS associated oral lesion in Zimbabwe?","volume":"10","author":"Chidzonga","year":"2004","journal-title":"Oral Dis"},{"issue":"2","key":"10.1016\/j.disamonth.2021.101167_bib0030","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/0253-7184.85415","article-title":"Kaposi\u2032s sarcoma as a presenting manifestation of HIV","volume":"32","author":"Mehta","year":"2011","journal-title":"Indian J Sex Transm Dis AIDS"},{"issue":"1","key":"10.1016\/j.disamonth.2021.101167_bib0031","first-page":"51","article-title":"Violaceous papulonodular lesions in an AIDS case","volume":"29","author":"Bhagat","year":"2008","journal-title":"Indian J Sex Transm Dis"},{"issue":"2","key":"10.1016\/j.disamonth.2021.101167_bib0032","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5070\/D32304K6W2","article-title":"AIDS-associated Kaposi's sarcoma in a heterosexual male\u2013a case report","volume":"8","author":"Chandan","year":"2002","journal-title":"Dermatol Online J"},{"issue":"2","key":"10.1016\/j.disamonth.2021.101167_bib0033","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4103\/0976-9668.160041","article-title":"Oral Kaposi\u2032s sarcoma: sole presentation in HIV seropositive patient","volume":"6","author":"Arul","year":"2015","journal-title":"J Nat Sci Biol Med"},{"issue":"1","key":"10.1016\/j.disamonth.2021.101167_bib0034","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/QAD.0000000000001671","article-title":"Benefits and risks of rapid initiation of antiretroviral therapy","volume":"32","author":"Ford","year":"2018","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.disamonth.2021.101167_bib0035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.2016.8900","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults","volume":"316","author":"G\u00fcnthard","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.disamonth.2021.101167_bib0036","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.disamonth.2021.101167_bib0037","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2012.7961","article-title":"Antiretroviral treatment of adult HIV infection","volume":"308","author":"Thompson","year":"2012","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.disamonth.2021.101167_bib0038","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1056\/NEJMoa0906768","article-title":"Abacavir\u2013lamivudine versus Tenofovir\u2013Emtricitabine for initial HIV-1 therapy","volume":"361","author":"Sax","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.disamonth.2021.101167_bib0039","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/QAI.0b013e3181dd911e","article-title":"Randomized comparison of renal effects, efficacy, and safety with once-daily Abacavir\/Lamivudine versus Tenofovir\/Emtricitabine, administered with Efavirenz, in antiretroviral-naive, HIV-1\u2013infected adults: 48-week results from the ASSERT study","volume":"55","author":"Post","year":"2010","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"11","key":"10.1016\/j.disamonth.2021.101167_bib0040","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ijom.2017.06.008","article-title":"Impact of highly active antiretroviral therapy on the prevalence of oral lesions in HIV-positive patients: a systematic review and meta-analysis","volume":"46","author":"de Almeida","year":"2017","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"1","key":"10.1016\/j.disamonth.2021.101167_bib0041","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/0253-7184.156703","article-title":"Impact of highly active antiretroviral therapy on oral manifestations of patients with human immunodeficiency virus\/acquired immuno deficiency syndrome in South India","volume":"36","author":"Chitturi","year":"2015","journal-title":"Indian J Sex Transm Dis AIDS"},{"issue":"9","key":"10.1016\/j.disamonth.2021.101167_bib0042","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ooe.2005.06.006","article-title":"Management of oral Kaposi's sarcoma lesions on HIV-positive patient using highly active antiretroviral therapy: case report and a review of the literature","volume":"41","author":"Shetty","year":"2005","journal-title":"Oral Oncol Extra"},{"issue":"1","key":"10.1016\/j.disamonth.2021.101167_bib0043","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1472-6831-6-12","article-title":"Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania","volume":"6","author":"Hamza","year":"2006","journal-title":"BMC Oral Health"},{"issue":"2","key":"10.1016\/j.disamonth.2021.101167_bib0044","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9020088","article-title":"Oral manifestations in HIV-positive children: a systematic review","volume":"9","author":"Lauritano","year":"2020","journal-title":"Pathogens"}],"container-title":["Disease-a-Month"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502921000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011502921000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T01:02:20Z","timestamp":1757898140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011502921000419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0011502921000419"],"URL":"https:\/\/doi.org\/10.1016\/j.disamonth.2021.101167","relation":{},"ISSN":["0011-5029"],"issn-type":[{"value":"0011-5029","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reviewing the oral pigmented lesions of human immunodeficiency virus with emphasis on the effect of highly active antiretroviral therapy","name":"articletitle","label":"Article Title"},{"value":"Disease-a-Month","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.disamonth.2021.101167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101167"}}